跳转至内容
Merck
CN
  • Endothelial failure after collagen cross-linking with riboflavin and UV-A: case report with literature review.

Endothelial failure after collagen cross-linking with riboflavin and UV-A: case report with literature review.

Cornea (2012-09-11)
Bhupesh Bagga, Shivani Pahuja, Somasheila Murthy, Virendra S Sangwan
摘要

To report a case of endothelial decompensation after a collagen cross-linking (CXL) procedure for keratoconus. An 18-year-old boy had CXL for keratoconus in the right eye. He developed keratouveitis with generalized corneal edema seen 3 weeks after the procedure. Polymerase chain reaction for aqueous humor Herpes simplex virus was negative. The patient was treated with topical steroids. Specular microscopy revealed mildly reduced density of endothelial cells. On follow-up to 6 months, corneal edema increased with the formation of epithelial bullae. Penetrating keratoplasty was performed. Possible causes for this complication are discussed. Clinical and histopathological analyses revealed generalized loss of endothelial cells along with signs of inflammation. Although it is considered very safe, collagen CXL can cause severe keratouveitis and endothelial failure.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
(−)-核黄素, from Eremothecium ashbyii, ≥98%
Supelco
核黄素 (B2), analytical standard
Sigma-Aldrich
(−)-核黄素, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
Supelco
核黄素, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(−)-核黄素, meets USP testing specifications
USP
核黄素, United States Pharmacopeia (USP) Reference Standard
核黄素, European Pharmacopoeia (EP) Reference Standard
(−)-核黄素, European Pharmacopoeia (EP) Reference Standard